Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation

被引:28
作者
Catalano, A
Carocci, A
Fracchiolla, G
Franchini, C
Lentini, G
Tortorella, V
De Luca, A
De Bellis, M
Desaphy, JF
Camerino, DC
机构
[1] Univ Bari, Dipartimento Farmaco Chim, Fac Farm, I-70126 Bari, Italy
[2] Univ Bari, Dipartimento Farmaco Biol, Fac Farm, I-70126 Bari, Italy
关键词
mexiletine; metabolites; use-dependent block; enantiomers; absolute configuration; enantiomeric excess;
D O I
10.1002/chir.10307
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Both enantiomers of "para-hydroxymexiletine" (PHM), one of the main metabolites of mexiletine, were synthesized and fully characterized. Properties of (R)- and (S)-PHM, in terms of blocking potency and stereoselectivity on frog skeletal muscle Na+ channels, were evaluated. The presence of a hydroxy group on the aryloxy moiety in the 4-position, as in PHM, reduced potency with respect to mexiletine in reducing I-Na (max). However, PHM showed clear use-dependent behavior similar to that of mexiletine and, in contrast with what is observed with the parent compound, maintained its stereoselectivity during the use-dependent block. (C) 2004Wiley-Liss, Inc.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 34 条
[1]  
Abounassif M.A., 1991, ANAL PROFILES DRUG S, V20, P433
[2]   Synthesis and beta-adrenergic activities of R-fluoronaphthyloxypropanolamine [J].
Adejare, A ;
Sciberras, SS .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :533-536
[3]   IDENTIFICATION AND ANALYSIS OF MEXILETINE AND ITS METABOLIC PRODUCTS IN MAN [J].
BECKETT, AH ;
CHIDOMERE, EC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (05) :281-285
[4]  
BECKETT AH, 1977, POSTGRAD MED J, V53, P60
[5]   CHIRAL ALPHA-SUBSTITUTED ALPHA-ARYLOXY ACETIC-ACIDS - SYNTHESIS, ABSOLUTE-CONFIGURATION, CHEMICAL RESOLUTION, AND DIRECT SEPARATION BY HPLC [J].
BETTONI, G ;
FERORELLI, S ;
LOIODICE, F ;
TANGARI, N ;
TORTORELLA, V ;
GASPARRINI, F ;
MISITI, D ;
VILLANI, C .
CHIRALITY, 1992, 4 (03) :193-203
[6]   A PROCEDURE FOR PHTHALOYLATION UNDER MILD CONDITIONS [J].
BOSE, AK ;
GREER, F ;
PRICE, CC .
JOURNAL OF ORGANIC CHEMISTRY, 1958, 23 (09) :1335-1338
[7]  
BROLY F, 1990, DRUG METAB DISPOS, V18, P362
[8]   INHIBITORY STUDIES OF MEXILETINE AND DEXTROMETHORPHAN OXIDATION IN HUMAN LIVER-MICROSOMES [J].
BROLY, F ;
LIBERSA, C ;
LHERMITTE, M ;
DUPUIS, B .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (06) :1045-1053
[9]   THE METABOLISM OF MEXILETINE IN RELATION TO THE DEBRISOQUINE SPARTEINE-TYPE POLYMORPHISM OF DRUG OXIDATION [J].
BROLY, F ;
VANDAMME, N ;
LIBERSA, C ;
LHERMITTE, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) :459-466
[10]  
CAMPBELL NPS, 1978, BRIT J CLIN PHARMACO, V6, P103, DOI 10.1111/j.1365-2125.1978.tb00833.x